Science Current Events | Science News | Brightsurf.com
 

Antibiotic Treatment Current Events | Antibiotic Treatment News | 8

Sort By: Page Views | Date

Drug dosages often incorrect for obese patients
As if severely overweight people didn't already have enough health concerns, experts are raising another red flag - the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.   view more (2007-11-16)

UT Southwestern physician helps craft first guidelines for care, diagnosis of swimmer's ear
Antiseptic or antibiotic ear drops should be the front-line treatment for people suffering from swimmer's ear, while restraint should be exercised in using oral antibiotics, according to new treatment guidelines issued as the nation's public pools prepare to open around Memorial Day.   view more (2006-05-18)

Biomedical engineers' detective work reveals antibiotic mechanism
A series of genetic clues led a team of Boston University biomedical engineers to uncover exactly how certain antibiotics kill bacteria. The findings could help rejuvenate the efficacy of older antibiotics and reveal new antibiotic targets within bacterial cells.   view more (2008-11-18)

Zinc can help in the treatment of pneumonia (pp 1683)
The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of THE LANCET. Pneumonia is a leading cause of mortality and morbidity in children less than five years old. Zinc is reported to prevent pneumonia, and to prevent and treat diarrhoea, and it may boost the body's... view more... (2004-05-19)

Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
An antibiotic commonly used to treat a variety of serious infections may also help prevent dementia in HIV patients, according to a test-tube study of human brain cells by Johns Hopkins University School of Medicine neurologist Jeffrey Rumbaugh, M.D., Ph.D.   view more (2006-04-06)

Unique fungal collection could hold key to future antibiotics
Royal Holloway and CABI both bring a combination of individual scientific skills, expertise and resources to the project. When brought together, these offer the opportunity to build a highly focused natural products drug discovery operation that will address the urgent need for bringing new antibiotic compounds to market.   view more (2008-01-23)

Antibiotic inhibits cancer gene activity
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors.   view more (2006-10-02)

Older antibiotic gains new respect as potent treatment for tuberculosis
It has no current market, not even a prescription price. Its makers stopped commercial production years ago, because demand was so low.   view more (2007-12-18)

Early treatment of stomach infection may prevent cancer
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer.   view more (2008-05-01)

University of Virginia Study Reveals Promising Method for Reducing MRSA Infections in Hospital Intensive Care Units
Doctors at the University of Virginia Health System have significantly reduced MRSA infections among surgical intensive care patients by using antibiotic cycling, a method of rotating drugs at regular intervals.    view more (2008-09-05)

Early switch from IV to oral meds is effective for children with acute bone infection
When treating hospitalized children with acute osteomyelitis--a bacterial bone infection--an early changeover from intravenous (IV) antibiotic delivery to oral antibiotics is just as effective as continuing the IV therapy, according to pediatric researchers.   view more (2009-02-12)

Targeting wolbachia, doxycycline reduces pathology of lymphatic filariasis
Lymphatic filariasis, a mosquito-borne tropical disease that afflicts 120 million people worldwide, can cause debilitating swelling of the legs and genital areas.   view more (2006-09-20)

Preventing tuberculosis reactivation
Tuberculosis (TB) is the leading cause of death due to infectious disease in the world today. It is estimated that 2 billion people are currently infected, and although most people have latent infection, reactivation can occur.   view more (2007-10-18)

New anthrax inhibitor could combat antibiotic-resistant strains
In a new approach to treating anthrax exposure, a team of scientists has created an inhibitor designed to tackle the growing threat of antibiotic-resistant strains.   view more (2006-08-29)

Community MRSA is re-emergence of 1950s pandemic, study suggests
An early type of antibiotic-resistant bacteria that caused a global epidemic of infections in the 1950s has re-emerged as one of the community-acquired MRSA 'superbugs', according to a study published in this weeks issue of The Lancet.   view more (2005-03-31)

Community-acquired staph pneumonia appears more common, including MRSA
Preliminary research from the Centers for Disease Control and Prevention (CDC) suggests that community acquired pneumonia (CAP) caused by the Staphylococcus aureus bacterium may be more common than originally suspected, including that caused by antibiotic resistant strains.   view more (2008-03-20)

Study shows antibiotic-resistant bacteria responsible for increase in muscle infections
Researchers in Houston, Texas have found two bacterial muscle infections common in tropical countries becoming more frequent occurrences along with the emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).   view more (2006-09-07)

ESC Congress 2004: New findings from ground-breaking PROVE IT-TIMI 22 clinical trial
Study Finds Antibiotics Do Not Prevent Heart Attacks   view more (2004-08-30)

New antibiotic drug combo to speed up treatment of tuberculosis
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.   view more (2007-09-19)

E. coli engineered to produce important class of antibiotic, anti-cancer drugs
Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have taken a major step forward in the field of metabolic engineering, successfully using the bacterium Escherichia coli to synthesize a class of natural products known bacterial aromatic polyketides, which include important antibiotic and anticancer drugs.   view more (2008-12-23)
Sort By: Page Views | Date
© 2009 BrightSurf.com